{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:56:12Z","timestamp":1785783372323,"version":"3.56.0"},"reference-count":46,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council (NHMRC)","doi-asserted-by":"publisher","award":["GNT1174405"],"award-info":[{"award-number":["GNT1174405"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victorian Government\u2019s Operational Infrastructure Support Program","award":["GNT1174405"],"award-info":[{"award-number":["GNT1174405"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>The development and approval of antivirals against SARS-CoV-2 has further equipped clinicians with treatment strategies against the COVID-19 pandemic, reducing deaths post-infection. Extensive clinical use of antivirals, however, can impart additional selective pressure, leading to the emergence of antiviral resistance. While we have previously characterized possible effects of circulating SARS-CoV-2 missense mutations on proteome function and stability, their direct effects on the novel antivirals remains unexplored. To address this, we have computationally calculated the consequences of mutations in the antiviral targets: RNA-dependent RNA polymerase and main protease, on target stability and interactions with their antiviral, nucleic acids, and other proteins. By analyzing circulating variants prior to antiviral approval, this work highlighted the inherent resistance potential of different genome regions. Namely, within the main protease binding site, missense mutations imparted a lower fitness cost, while the opposite was noted for the RNA-dependent RNA polymerase binding site. This suggests that resistance to nirmatrelvir\/ritonavir combination treatment is more likely to occur and proliferate than that to molnupiravir. These insights are crucial both clinically in drug stewardship, and preclinically in the identification of less mutable targets for novel therapeutic design.<\/jats:p>","DOI":"10.3390\/genes14091699","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T02:23:25Z","timestamp":1693189405000},"page":"1699","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identifying Innate Resistance Hotspots for SARS-CoV-2 Antivirals Using In Silico Protein Techniques"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-4301","authenticated-orcid":false,"given":"Stephanie","family":"Portelli","sequence":"first","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"},{"name":"Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Heaton","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2948-2413","authenticated-orcid":false,"given":"David B.","family":"Ascher","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia"},{"name":"Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: Implications for SARS-CoV-2","volume":"19","author":"Kratzel","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","first-page":"157","article-title":"WHO Declares COVID-19 a Pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41563-020-0746-0","article-title":"Next-generation vaccine platforms for COVID-19","volume":"19","year":"2020","journal-title":"Nat. Mater."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kumar, S., Chandele, A., and Sharma, A. (2021). Current status of therapeutic monoclonal antibodies against SARS-CoV-2. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009885"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cid\/ciac180","article-title":"Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs","volume":"76","author":"Saravolatz","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","unstructured":"WHO (2023). Statement on the Update of WHO\u2019s Working Definitions and Tracking System for SARS-CoV-2 Variants of Concern and Variants of Interest."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"eabj7364","DOI":"10.1126\/science.abj7364","article-title":"Vaccine nationalism and the dynamics and control of SARS-CoV-2","volume":"373","author":"Wagner","year":"2021","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients","volume":"386","author":"Musungaie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Venkataraman, S., Prasad, B., and Selvarajan, R. (2018). RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution. Viruses, 10.","DOI":"10.3390\/v10020076"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/jmv.27730","article-title":"Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2-A narrative review","volume":"94","author":"Masyeni","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hung, Y.P., Lee, J.C., Chiu, C.W., Lee, C.C., Tsai, P.J., Hsu, I.L., and Ko, W.C. (2022). Oral Nirmatrelvir\/Ritonavir Therapy for COVID-19: The Dawn in the Dark?. Antibiotics, 11.","DOI":"10.3390\/antibiotics11020220"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1021\/acs.biochem.2c00489","article-title":"Predicting Antiviral Resistance Mutations in SARS-CoV-2 Main Protease with Computational and Experimental Screening","volume":"61","author":"Sasi","year":"2022","journal-title":"Biochemistry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","volume":"613","author":"Iketani","year":"2023","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41588-020-0693-3","article-title":"Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource","volume":"52","author":"Portelli","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"954435","DOI":"10.3389\/fimmu.2022.954435","article-title":"A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility","volume":"13","author":"Boer","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15356","DOI":"10.1038\/s41598-018-33370-6","article-title":"Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis","volume":"8","author":"Portelli","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1164\/rccm.201712-2572LE","article-title":"Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy","volume":"198","author":"Karmakar","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Karmakar, M., Rodrigues, C.H.M., Holt, K.E., Dunstan, S.J., Denholm, J., and Ascher, D.B. (2019). Empirical ways to identify novel Bedaquiline resistance mutations in AtpE. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217169"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41598-020-58635-x","article-title":"Structure guided prediction of Pyrazinamide resistance mutations in pncA","volume":"10","author":"Karmakar","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1038\/s41598-018-23423-1","article-title":"Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae","volume":"8","author":"Vedithi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.csbj.2020.11.013","article-title":"HARP: A database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae","volume":"18","author":"Vedithi","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.csbj.2020.01.002","article-title":"Computational saturation mutagenesis to predict structural consequences of systematic mutations in the beta subunit of RNA polymerase in Mycobacterium leprae","volume":"18","author":"Vedithi","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_27","first-page":"e000165","article-title":"Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection","volume":"4","author":"Hawkey","year":"2018","journal-title":"Microb. Genom."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/srep04765","article-title":"Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA","volume":"4","author":"Ascher","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_29","first-page":"D84","article-title":"GenBank","volume":"48","author":"Sayers","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S2666-5247(20)30054-9","article-title":"An integrated national scale SARS-CoV-2 genomic surveillance network","volume":"1","author":"Consortium","year":"2020","journal-title":"Lancet Microbe"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/s41467-022-29915-z","article-title":"Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease","volume":"13","author":"Kneller","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J. Mol. Biol."},{"key":"ref_35","first-page":"W417","article-title":"mmCSM-lig: Accurate Prediction of the Effects of Mutations on Protein-Ligand Affinity","volume":"49","author":"Pires","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"W121","DOI":"10.1093\/nar\/gkz457","article-title":"MTR-Viewer: Identifying regions within genes under purifying selection","volume":"47","author":"Silk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1101\/gr.226589.117","article-title":"Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation","volume":"27","author":"Traynelis","year":"2017","journal-title":"Genome Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pro.3942","article-title":"DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations","volume":"30","author":"Rodrigues","year":"2021","journal-title":"Protein Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"W417","DOI":"10.1093\/nar\/gkab273","article-title":"mmCSM-PPI: Predicting the effects of multiple point mutations on protein\u2013protein interactions","volume":"49","author":"Rodrigues","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"W241","DOI":"10.1093\/nar\/gkx236","article-title":"mCSM\u2013NA: Predicting the effects of mutations on protein\u2013nucleic acids interactions","volume":"45","author":"Pires","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","article-title":"Biopython: Freely available Python tools for computational molecular biology and bioinformatics","volume":"25","author":"Cock","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jmb.2016.12.004","article-title":"Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures","volume":"429","author":"Jubb","year":"2017","journal-title":"J. Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41588-017-0029-0","article-title":"Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis","volume":"50","author":"Coll","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_44","unstructured":"Tibayrenc, M. (2011). Genetics and Evolution of Infectious Disease, Elsevier."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Jia, H., Xu, Y., and Sun, Z. (2021). Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111367"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"17755","DOI":"10.1038\/s41598-021-97267-7","article-title":"Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures","volume":"11","author":"Huallpa","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/9\/1699\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:39:48Z","timestamp":1760128788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/9\/1699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,26]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["genes14091699"],"URL":"https:\/\/doi.org\/10.3390\/genes14091699","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,26]]}}}